Literature DB >> 19864323

FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70.

Sarah M Senf1, Stephen L Dodd, Andrew R Judge.   

Abstract

The purpose of the current study was to determine whether heat shock protein 70 (Hsp70) directly regulates forkhead box O (FOXO) signaling in skeletal muscle. This aim stems from previous work demonstrating that Hsp70 overexpression inhibits disuse-induced FOXO transactivation and prevents muscle fiber atrophy. However, although FOXO is sufficient to cause muscle wasting, no data currently exist on the requirement of FOXO signaling in the progression of physiological muscle wasting, in vivo. In the current study we show that specific inhibition of FOXO, via expression of a dominant-negative FOXO3a, in rat soleus muscle during disuse prevented >40% of muscle fiber atrophy, demonstrating that FOXO signaling is required for disuse muscle atrophy. Subsequent experiments determined whether Hsp70 directly regulates FOXO3a signaling when independently activated in skeletal muscle, via transfection of FOXO3a. We show that Hsp70 inhibits FOXO3a-dependent transcription in a gene-specific manner. Specifically, Hsp70 inhibited FOXO3a-induced promoter activation of atrogin-1, but not MuRF1. Further studies showed that a FOXO3a DNA-binding mutant can activate MuRF1, but not atrogin-1, suggesting that FOXO3a activates these two genes through differential mechanisms. In summary, FOXO signaling is required for physiological muscle atrophy and is directly inhibited by Hsp70.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864323      PMCID: PMC2806148          DOI: 10.1152/ajpcell.00315.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  23 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.

Authors:  Jennifer M Sacheck; Jon-Philippe K Hyatt; Anna Raffaello; R Thomas Jagoe; Roland R Roy; V Reggie Edgerton; Stewart H Lecker; Alfred L Goldberg
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

Review 3.  FOXO-binding partners: it takes two to tango.

Authors:  K E van der Vos; P J Coffer
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

Review 4.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states.

Authors:  S H Lecker; V Solomon; W E Mitch; A L Goldberg
Journal:  J Nutr       Date:  1999-01       Impact factor: 4.798

5.  Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

6.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

7.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.

Authors:  David S Waddell; Leslie M Baehr; Jens van den Brandt; Steven A Johnsen; Holger M Reichardt; J David Furlow; Sue C Bodine
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

8.  Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy.

Authors:  Sarah M Senf; Stephen L Dodd; Joseph M McClung; Andrew R Judge
Journal:  FASEB J       Date:  2008-07-21       Impact factor: 5.191

9.  FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner.

Authors:  Thomas J McLoughlin; Sierra M Smith; Alissa D DeLong; Hengbing Wang; Terry G Unterman; Karyn A Esser
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-24       Impact factor: 4.249

10.  PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.

Authors:  Marco Sandri; Jiandie Lin; Christoph Handschin; Wenli Yang; Zoltan P Arany; Stewart H Lecker; Alfred L Goldberg; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

View more
  83 in total

1.  Foxo/atrogin induction in human and experimental myositis.

Authors:  Han-Kyu Lee; Edward Rocnik; Qinghao Fu; Bumsup Kwon; Ling Zeng; Kenneth Walsh; Henry Querfurth
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

Review 2.  Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity.

Authors:  Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2019-06       Impact factor: 43.330

3.  Serum extracellular vesicle miR-203a-3p content is associated with skeletal muscle mass and protein turnover during disuse atrophy and regrowth.

Authors:  Douglas W Van Pelt; Ivan J Vechetti; Marcus M Lawrence; Kathryn L Van Pelt; Parth Patel; Benjamin F Miller; Timothy A Butterfield; Esther E Dupont-Versteegden
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

Review 4.  Exercise: Teaching myocytes new tricks.

Authors:  Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2017-06-01

5.  Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle Regeneration.

Authors:  Wei Fan; Xiu Kui Gao; Xi Sheng Rao; Yin Pu Shi; Xiao Ceng Liu; Fei Ya Wang; Yu Fen Liu; Xiao Xia Cong; Min Yi He; Shui Bo Xu; Wei Liang Shen; Yue Shen; Shi Gui Yan; Yan Luo; Boon Chuan Low; Hongwei Ouyang; Zhang Bao; Li Ling Zheng; Yi Ting Zhou
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

6.  Impaired myogenesis in estrogen-related receptor γ (ERRγ)-deficient skeletal myocytes due to oxidative stress.

Authors:  Jennifer Murray; Johan Auwerx; Janice M Huss
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 7.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

8.  NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.

Authors:  Chia-Ling Wu; Evangeline W Cornwell; Robert W Jackman; Susan C Kandarian
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-19       Impact factor: 4.249

Review 9.  Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: A review of the causes and effects.

Authors:  Hayden Hyatt; Rafael Deminice; Toshinori Yoshihara; Scott K Powers
Journal:  Arch Biochem Biophys       Date:  2018-11-16       Impact factor: 4.013

10.  HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy.

Authors:  Adam W Beharry; Pooja B Sandesara; Brandon M Roberts; Leonardo F Ferreira; Sarah M Senf; Andrew R Judge
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.